Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- University of Cambridge
- ; Queen Mary University of London
- ; University of Dundee
- Aston University
- Durham University
- Heriot Watt University
- KINGS COLLEGE LONDON
- Manchester Metropolitan University
- Medical Research Council
- UNIVERSITY OF VIENNA
- University of Liverpool
- 3 more »
- « less
-
Field
-
Bandgap Semiconductor Device Technology) to accelerate the UK’s ambition for NetZero by transforming the next generation of high voltage electronic devices using wide/ultra-wide bandgap (WBG/UWBG) compound
-
About Us King’s College London is one of the world’s leading universities whose School of Cancer & Pharmaceutical Sciences unites basic, translational and clinical expertise to accelerate progress
-
Bandgap Semiconductor Device Technology) to accelerate the UK’s ambition for NetZero by transforming the next generation of high voltage electronic devices using wide/ultra-wide bandgap (WBG/UWBG) compound
-
. This is a unique opportunity to drive the commercialisation of a cutting-edge platform that accelerates peptide-based drug discovery. Peptide-based drugs present significant advantages over existing
-
)-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature 625, 189-194, doi:10.1038/s41586-023-06800-3 (2024). Van der Klaauw, A. A. et al. Accelerated waning of the humoral response to COVID-19 vaccines in
-
and accelerating the development of next-generation inorganic and hybrid crystalline semiconductors for the net-zero carbon transition. Materials explored will expand from an initial selection
-
This position involves working in a research team on the project “Accelerated carbon dioxide release from sedimentary rocks in a warming world” which is funded by the NERC Pushing the Frontiers
-
-of-the-art electrochemical techniques to investigate materials and diagnostic tools for energy conversion and storage technologies. As the PDRA, you will: Undertake research that accelerates innovation for our
-
About Us King’s College London is one of the world’s leading universities whose School of Cancer & Pharmaceutical Sciences unites basic, translational and clinical expertise to accelerate progress
-
materials discovery and machine-learning-accelerated materials simulation. You lead and guide the development of novel computational materials discovery and molecular simulation methods. You take a key role